{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T04:51:44Z","timestamp":1698727904636},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1994,10,1]],"date-time":"1994-10-01T00:00:00Z","timestamp":780969600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1994,10]]},"DOI":"10.1007\/bf01294784","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T22:50:58Z","timestamp":1111704658000},"page":"165-177","source":"Crossref","is-referenced-by-count":7,"title":["Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor"],"prefix":"10.1007","volume":"96","author":[{"given":"R. W.","family":"Fuller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. K.","family":"Hemrick-Luecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. D.","family":"Snoddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0014-2999(89)90363-4","volume":"166","author":"PH Anderson","year":"1989","unstructured":"Anderson PH (1989) The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur J Pharmacol 166: 493?504","journal-title":"Eur J Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.2042-7158.1992.tb05500.x","volume":"44","author":"M Anelli","year":"1992","unstructured":"Anelli M, Bizzi A, Caccia S, Codegoni AM, Fracasso C, Garattini S (1992) Anorectic activity of fluoxetine and norfluoxetine in mice, rats and guinea-pigs. J Pharm Pharmacol 44: 696?698","journal-title":"J Pharm Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0024-3205(88)90135-X","volume":"43","author":"I Angel","year":"1988","unstructured":"Angel I, Taranger M-A, Claustre Y, Scatton B, Langer SZ (1988) Anorectic activities of serotonin uptake inhibitors: correlation with their potencies at inhibiting serotonin uptake in vivo and3H-mazindol binding in vitro. Life Sci 43: 651?658","journal-title":"Life Sci"},{"key":"CR4","first-page":"45","volume-title":"Anorectic agents: mechanisms of action and tolerance","author":"SM Antelman","year":"1981","unstructured":"Antelman SM, Rowland N, Kocan C (1981) Anorectics: lack of cross tolerance among serotonergic drugs and sensitization of amphetamine's effect. In: Garattini S, Samanin R (eds) Anorectic agents: mechanisms of action and tolerance. Raven Press, New York, pp 45?62"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF02247717","volume":"109","author":"KE Asin","year":"1992","unstructured":"Asin KE, Davis JD, Bednarz L (1992) Differential effects of serotonergic and catecholaminergic drugs on ingestive behavior. Psychopharmacology 109: 415?421","journal-title":"Psychopharmacology"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1098-2337(1983)9:4<333::AID-AB2480090408>3.0.CO;2-R","volume":"9","author":"P Berzsenyi","year":"1983","unstructured":"Berzsenyi P, Galateo E, Valzelli L (1983) Fluoxetine activity on muricidal aggression induced in rats by p-chloroamphetamine. Aggress Behav 9: 333?338","journal-title":"Aggress Behav"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0028-3908(84)90098-4","volume":"23","author":"JE Blundell","year":"1984","unstructured":"Blundell JE (1984) Serotonin and appetite. Neuropharmacology 23: 1537?1551","journal-title":"Neuropharmacology"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0024-3205(93)90194-8","volume":"52","author":"C Bolden-Watson","year":"1993","unstructured":"Bolden-Watson C, Richelson E (1993) Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 52: 1023?1029","journal-title":"Life Sci"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.2042-7158.1992.tb03592.x","volume":"44","author":"S Caccia","year":"1992","unstructured":"Caccia S, Bizzi A, Coltro G, Fracasso C, Frittoli E, Mennini T, Garattini S (1992) Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms. J Pharm Pharmacol 44: 250?254","journal-title":"J Pharm Pharmacol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/0024-3205(85)90557-0","volume":"36","author":"MO Carruba","year":"1985","unstructured":"Carruba MO, Ricciardi S, Spano P, Mantegazza P (1985) Dopaminergic and serotoninergic anorectics differentially antagonize insulin- and D2-DG-induced hyperphagia. Life Sci 36: 1739?1749","journal-title":"Life Sci"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1210\/endo-100-3-692","volume":"100","author":"JA Clemens","year":"1977","unstructured":"Clemens JA, Sawyer BD, Cerimele B (1977) Further evidence that serotonin is a neurotransmitter involved in the control of prolactin secretion. Endocrinology 100: 692?698","journal-title":"Endocrinology"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00443419","volume":"97","author":"PG Clifton","year":"1989","unstructured":"Clifton PG, Barnfield AM, Philcox L (1989) A behavioural profile of fluoxetine-induced anorexia. Psychopharmacology 97: 89?95","journal-title":"Psychopharmacology"},{"key":"CR13","first-page":"127","volume":"215","author":"BR Cooper","year":"1980","unstructured":"Cooper BR, Hester TJ, Maxwell RA (1980) Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J Pharmacol Exp Ther 215: 127?134","journal-title":"J Pharmacol Exp Ther"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0091-3057(90)90203-T","volume":"35","author":"SJ Cooper","year":"1990","unstructured":"Cooper SJ, Dourish CT, Barber DJ (1990) Fluoxetine reduces food intake by a cholecystokinin-independent mechanism. Pharmacol Biochem Behav 35: 51?54","journal-title":"Pharmacol Biochem Behav"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/0024-3205(88)90131-2","volume":"42","author":"G Renzo Di","year":"1988","unstructured":"Di Renzo G, Amoroso S, Taglialatela M, Canzoniero LM, Maida P, Lombardi G, Annunziato L (1988) Pure uptake blockers of dopamine can reduce prolactin secretion: studies with diclofensine. Life Sci 42: 2161?2169","journal-title":"Life Sci"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0006-2952(74)90217-2","volume":"23","author":"RL Dorris","year":"1974","unstructured":"Dorris RL, Shore P (1974) Interaction of apomorphine, neuroleptics and stimulants with ?-methyl-m-tyramine, a false dopaminergic transmitter. Biochem Pharmacol 23: 867?872","journal-title":"Biochem Pharmacol"},{"key":"CR17","first-page":"179","volume":"85","author":"CT Dourish","year":"1992","unstructured":"Dourish CT (1992) 5-HT receptor subtypes and feeding behaviour. Adv Biosci 85: 179?202","journal-title":"Adv Biosci"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-349-10997-5_6","volume-title":"Current aspects of the neurosciences, vol 1","author":"RW Fuller","year":"1990","unstructured":"Fuller RW (1990) MPTP: a parkinsonism-causing neurotoxic substance. In: Osborne NN (ed) Current aspects of the neurosciences, vol 1. Macmillan, London Basingstoke, pp 183?201"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.7384808","volume":"209","author":"RW Fuller","year":"1980","unstructured":"Fuller RW, Hemrick-Luecke SK (1980) Long-lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats by amphetamine. Science 209: 395?397","journal-title":"Science"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0028-3908(82)90027-2","volume":"21","author":"RW Fuller","year":"1982","unstructured":"Fuller RW, Hemrick-Luecke SK (1982) Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine. Neuropharmacology 21: 433?438","journal-title":"Neuropharmacology"},{"key":"CR21","first-page":"50","volume":"248","author":"RW Fuller","year":"1989","unstructured":"Fuller RW, Perry KW (1989) Effects of buspirone and its metabolite, l-(2-pyrimidinyl) piperazine, on brain monoamines and their metabolites in rats. J Pharmacol Exp Ther 248: 50?56","journal-title":"J Pharmacol Exp Ther"},{"key":"CR22","first-page":"796","volume":"193","author":"RW Fuller","year":"1975","unstructured":"Fuller RW, Perry KW, Molloy BB (1975) Effect of 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine. J Pharmacol Exp Ther 193: 796?803","journal-title":"J Pharmacol Exp Ther"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0014-2999(74)90139-3","volume":"28","author":"RW Fuller","year":"1974","unstructured":"Fuller RW, Perry KW, Snoddy HD, Molloy BB (1974) Comparison of the specificity of 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine and chlorimipramine as amine uptake inhibitors in mice. Eur J Pharmacol 28: 233?236","journal-title":"Eur J Pharmacol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF01252698","volume":"44","author":"RW Fuller","year":"1979","unstructured":"Fuller RW, Snoddy HD (1979) Effect of mazindol on brain dopamine turnover in spiperone-treated rats. J Neural Transm 44: 13?19","journal-title":"J Neural Transm"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0091-3057(88)90089-5","volume":"30","author":"RW Fuller","year":"1988","unstructured":"Fuller RW, Snoddy HD, Robertson DW (1988) Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release. Pharmacol Biochem Behav 30: 715?721","journal-title":"Pharmacol Biochem Behav"},{"key":"CR26","first-page":"2154","volume":"36","author":"RW Fuller","year":"1977","unstructured":"Fuller RW, Wong DT (1977) Inhibition of serotonin uptake. Fed Proc 36: 2154?2158","journal-title":"Fed Proc"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ddr.430170102","volume":"17","author":"RW Fuller","year":"1989","unstructured":"Fuller RW, Wong DT (1989) Fluoxetine: a serotonergic appetite suppressant drug. Drug Dev Res 17: 1?15","journal-title":"Drug Dev Res"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1093\/ajcn\/55.1.160s","volume":"55","author":"S Garattini","year":"1992","unstructured":"Garattini S, Bizzi A, Codegoni AM, Caccia S, Mennini T (1992) Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system. Am J Clin Nutr 55: 160S-166S","journal-title":"Am J Clin Nutr"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.2042-7158.1976.tb04165.x","volume":"28","author":"AJ Goudie","year":"1976","unstructured":"Goudie AJ, Thornton EW, Wheeler TJ (1976) Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotonergic inhibition of feeding. J Pharm Pharmacol 28: 318?320","journal-title":"J Pharm Pharmacol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0028-3908(92)90082-Z","volume":"31","author":"G Grignaschi","year":"1992","unstructured":"Grignaschi G, Samanin R (1992) Role of serotonin and catecholamines in brain in the feeding suppressant effect of fluoxetine. Neuropharmacology 31: 445?449","journal-title":"Neuropharmacology"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-2999(84)90483-7","volume":"103","author":"RE Heikkila","year":"1984","unstructured":"Heikkila RE, Manzino L (1984) Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake. Eur J Pharmacol 103: 241?248","journal-title":"Eur J Pharmacol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1254\/jjp.55.501","volume":"55","author":"K Hirate","year":"1991","unstructured":"Hirate K, Kuribara H (1991) Characteristics of the ambulation-increasing effect of GBR- 12909, a selective dopamine uptake inhibitor, in mice. Jpn J Pharmacol 55: 501?511","journal-title":"Jpn J Pharmacol"},{"key":"CR33","first-page":"257","volume":"214","author":"AJ Hotchkiss","year":"1980","unstructured":"Hotchkiss AJ, Gibb JW (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther 214: 257?262","journal-title":"J Pharmacol Exp Ther"},{"key":"CR34","first-page":"653","volume":"73","author":"HJ Hrishi Keshavan","year":"1981","unstructured":"Hrishi Keshavan HJ, Gurbani NK, Dandiya PC (1981) Effect of fluoxetine on a specific serotonergic syndrome in rats. Ind J Med Res 73: 653?657","journal-title":"Ind J Med Res"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-2999(89)90066-6","volume":"166","author":"YL Hurd","year":"1989","unstructured":"Hurd YL, Ungerstedt U (1989) In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur J Pharmacol 166: 251?260","journal-title":"Eur J Pharmacol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0278-5846(82)80179-6","volume":"6","author":"J Hyttel","year":"1982","unstructured":"Hyttel J (1982) Citalopram ? pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 6: 277?295","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(90)91719-W","volume":"520","author":"S Izenwasser","year":"1990","unstructured":"Izenwasser S, Werling LL, Cox BM (1990) Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex. Brain Res 520: 303?309","journal-title":"Brain Res"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0091-3057(77)90144-7","volume":"7","author":"RJ Katz","year":"1977","unstructured":"Katz RJ, Baldrighi G, Carroll BJ (1977) Effects of nomifensine (HOE 984) upon psychomotor activity and intracranial self-stimulation in the rat. Pharmacol Biochem Behav 7: 269?272","journal-title":"Pharmacol Biochem Behav"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0014-2999(89)90447-0","volume":"167","author":"AE Kelley","year":"1989","unstructured":"Kelley AE, Lang CG (1989) Effects of GBR 12909, a selective dopamine uptake inhibitor, on motor activity and operant behavior in the rat. Eur J Pharmacol 167: 385?395","journal-title":"Eur J Pharmacol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0031-9384(88)90272-7","volume":"42","author":"SH Kim","year":"1988","unstructured":"Kim SH, Wurtman RJ (1988) Selective effects of CGS 10686B, dl-fenfluramine or fluoxetine on nutrient selection. Physiol Behav 42: 319?322","journal-title":"Physiol Behav"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/newbio246052a0","volume":"246","author":"ZL Kruk","year":"1973","unstructured":"Kruk ZL (1973) Dopamine and 5-hydroxytryptamine inhibit feeding in rats. Nature New Biol 246: 52?53","journal-title":"Nature New Biol"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0024-3205(75)90336-7","volume":"17","author":"L Krulich","year":"1975","unstructured":"Krulich L (1975) The effect of a serotonin uptake inhibitor (Lilly 110140) on the secretion of prolactin in the rat. Life Sci 17: 1141?1144","journal-title":"Life Sci"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0006-8993(84)90928-4","volume":"308","author":"GJ Lees","year":"1984","unstructured":"Lees GJ, Kydd RR, Horsburgh RJ, Wright JJ (1984) Effect of nomifensine on the toxicity of 6-hydroxydopamine for mesotelencephalic dopamine neurons. Brain Res 308: 155?158","journal-title":"Brain Res"},{"issue":"Suppl 3","key":"CR44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003495-199000393-00005","volume":"39","author":"SF Leibowitz","year":"1990","unstructured":"Leibowitz SF (1990) The role of serotonin in eating disorders. Drugs 39 [Suppl 3]: 33?48","journal-title":"Drugs"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0091-3057(93)90103-Z","volume":"45","author":"SF Leibowitz","year":"1993","unstructured":"Leibowitz SF, Alexander JT, Cheung WK, Weiss GF (1993) Effects of serotonin and the serotonin blocker metergoline on meal patterns and macronutrient selection. Pharmacol Biochem Behav 45: 185?194","journal-title":"Pharmacol Biochem Behav"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0361-9230(90)90130-R","volume":"24","author":"SQ Luo","year":"1990","unstructured":"Luo SQ, Li ET (1990) Food intake and selection pattern of rats treated with dexfenfluramine, fluoxetine and RU 24969. Brain Res Bull 24: 729?733","journal-title":"Brain Res Bull"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0024-3205(90)90378-5","volume":"46","author":"SQ Luo","year":"1990","unstructured":"Luo SQ, Ransom T, Li ET (1990) Selective increase in carbohydrate intake by rats treated with 8-hydroxy-2-(di-n-propylamino)-tetraline or buspirone. Life Sci 46: 1643?1648","journal-title":"Life Sci"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/acps.1980.61.s280.97","volume":"61","author":"L Maitre","year":"1980","unstructured":"Maitre L, Moser P, Baumann PA, Waldmeier PC (1980) Amine uptake inhibitors: criteria of selectivity. Acta Psychiatr Scand 61 [Suppl]: 97?110","journal-title":"Acta Psychiatr Scand"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0006-8993(90)90467-P","volume":"513","author":"GJ Marek","year":"1990","unstructured":"Marek GJ, Vosmer G, Seiden LS (1990) Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons. Brain Res 513: 274?279","journal-title":"Brain Res"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0014-2999(85)90201-8","volume":"116","author":"E Melamed","year":"1985","unstructured":"Melamed E, Rosenthal J, Cohen O, Globus M, Uzzan A (1985) Dopamine but not nor-epinephrine or serotonin uptake inhibitors protect mice against neurotoxicvity of MPTP. Eur J Pharmacol 116: 179?181","journal-title":"Eur J Pharmacol"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0028-3908(76)90024-1","volume":"15","author":"RB Messing","year":"1976","unstructured":"Messing RB, Phebus L, Fisher LA, Lytle LD (1976) Effects of p-chloroamphetamine on locomotor activity and brain 5-hydroxyindoles. Neuropharmacology 15: 157?163","journal-title":"Neuropharmacology"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0006-2952(78)90152-1","volume":"27","author":"SE Mireylees","year":"1978","unstructured":"Mireylees SE, Goodlet I, Sugrue MF (1978) Effects of Org 6582 on monoamine uptake in vitro. Biochem Pharmacol 27: 1023?1027","journal-title":"Biochem Pharmacol"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1210\/endo-103-4-1016","volume":"103","author":"WW Morgan","year":"1978","unstructured":"Morgan WW, Herbert DC (1978) Elevation of serum prolactin levels after the inhibition of serotonin uptake. Endocrinology 103: 1016?1022","journal-title":"Endocrinology"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1172\/JCI109121","volume":"62","author":"GS Omenn","year":"1978","unstructured":"Omenn GS, Smith LT (1978) A common uptake system for serotonin and dopamine concentration in microdialysis fluid from rat striatum. J Clin Invest 62: 235?240","journal-title":"J Clin Invest"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/0024-3205(92)90423-M","volume":"50","author":"KW Perry","year":"1992","unstructured":"Perry KW, Fuller RW (1992) Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci 50: 1683?1690","journal-title":"Life Sci"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0006-8993(84)91273-3","volume":"291","author":"GA Ricaurte","year":"1984","unstructured":"Ricaurte GA, Guillery RW, Seiden LS, Schuster CR (1984) Nerve terminal degeneration after a single injection of D-amphetamine in iprindole-treated rats: relation to selective long-lasting dopamine depletion. Brain Res 291: 378?382","journal-title":"Brain Res"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0024-3205(79)90126-7","volume":"24","author":"SB Ross","year":"1979","unstructured":"Ross SB (1979) The central stimulatory action of inhibitors of the dopamine uptake. Life Sci 24: 159?167","journal-title":"Life Sci"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0091-3057(91)90570-R","volume":"40","author":"RB Rothman","year":"1991","unstructured":"Rothman RB, Mele A, Reid AA, Akunne HC, Greig N, Thurkauf A, de Costa BR, Rice KC, Pert A (1991) GBR 12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine. Pharmacol Biochem Behav 40: 387?397","journal-title":"Pharmacol Biochem Behav"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-2999(82)90601-X","volume":"81","author":"NE Rowland","year":"1982","unstructured":"Rowland NE, Antelman SM, Kocan D (1982) Differences among serotonergic anorectics in a cross-tolerance paradigm: do they all act on serotonin systems? Eur J Pharmacol 81: 57?66","journal-title":"Eur J Pharmacol"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-2999(75)90266-6","volume":"34","author":"R Samanin","year":"1975","unstructured":"Samanin R, Bernasconi S, Garattini S (1975) The effect of nomifensine on the depletion of brain serotonin and catecholamines induced respectively by fenfluramine and 6-hydroxydopamine in rats. Eur J Pharmacol 34: 377?380","journal-title":"Eur J Pharmacol"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ddr.430120103","volume":"12","author":"B Scatton","year":"1988","unstructured":"Scatton B, Claustre Y, Graham D, Dennis T, Serrano A, Arbilla S, Pimoule C, Schoemaker H, Bigg D, Langer SZ (1988) SL 81-0385: a novel selective and potent serotonin uptake inhibitor. Drug Dev Res 12: 29?40","journal-title":"Drug Dev Res"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(85)90541-2","volume":"109","author":"CJ Schmidt","year":"1985","unstructured":"Schmidt CJ, Gibb JW (1985) Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid. Eur J Pharmacol 109: 73?80","journal-title":"Eur J Pharmacol"},{"key":"CR63","first-page":"1032","volume":"247","author":"RP Shank","year":"1988","unstructured":"Shank RP, Vaught JL, Pelley KA, Setler PE, McComsey DF, Maryanoff BE (1988) McN-5662: a highly potent inhibitor of serotonin uptake. J Pharmacol Exp Ther 247: 1032?1038","journal-title":"J Pharmacol Exp Ther"},{"key":"CR64","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.2042-7158.1976.tb04078.x","volume":"28","author":"PA Shore","year":"1976","unstructured":"Shore PA (1976) Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron. J Pharm Pharmacol 28: 855?857","journal-title":"J Pharm Pharmacol"},{"key":"CR65","first-page":"7","volume":"46","author":"P Stark","year":"1985","unstructured":"Stark P, Fuller RW, Wong DT (1985) The pharmacologic profile of fluoxetine. J Clin Psychiatry 46: 7?13","journal-title":"J Clin Psychiatry"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0006-8993(82)90477-2","volume":"234","author":"LR Steranka","year":"1982","unstructured":"Steranka LR (1982) Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid. Brain Res 234: 123?136","journal-title":"Brain Res"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF02244365","volume":"105","author":"GF Weiss","year":"1991","unstructured":"Weiss GF, Rogacki N, Fueg A, Buchen D, Suh JS, Wong DT, Leibowitz SF (1991) Effect of hypothalamic and peripheral fluoxetine injection on natural patterns of macronutrient intake in the rat. Psychopharmacology 105: 467?476","journal-title":"Psychopharmacology"},{"key":"CR68","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0024-3205(78)90664-1","volume":"23","author":"DT Wong","year":"1978","unstructured":"Wong DT, Bymaster FP (1978) An inhibitor of dopamine uptake, LR5182, dis-3-(3,4-dichlorophenyl)-2-N, N-dimethylaminomethyl-bicyclo-[2, 2, 2]-octane, hydrochloride. Life Sci 23: 1041?1048","journal-title":"Life Sci"},{"key":"CR69","first-page":"804","volume":"193","author":"DT Wong","year":"1975","unstructured":"Wong DT, Bymaster FP, Horng JS, Molloy BB (1975) A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. J Pharmacol Exp Ther 193: 804?811","journal-title":"J Pharmacol Exp Ther"},{"key":"CR70","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0091-3057(88)90376-0","volume":"31","author":"DT Wong","year":"1988","unstructured":"Wong DT, Reid LR, Threlkeld PG (1988) Suppression of food intake by fluoxetine: comparison of enantiomers and effects of serotonin antagonists. Pharmacol Biochem Behav 31: 475?479","journal-title":"Pharmacol Biochem Behav"},{"key":"CR71","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1126\/science.929195","volume":"198","author":"JJ Wurtman","year":"1977","unstructured":"Wurtman JJ, Wurtman RJ (1977) Fenfluramine and fluoxetine spare protein consumption while suppressing caloric intake by rats. Science 198: 1178?1180","journal-title":"Science"},{"issue":"Suppl 1","key":"CR72","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1185\/03007997909117489","volume":"6","author":"JJ Wurtman","year":"1979","unstructured":"Wurtman JJ, Wurtman RJ (1979) Fenfluramine and other serotonergic drugs depress food intake and carbohydrate consumption while sparing protein consumption. Curr Med Res Opin 6 [Suppl 1]: 28?33","journal-title":"Curr Med Res Opin"},{"key":"CR73","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0014-2999(76)90094-7","volume":"36","author":"F Zambotti","year":"1976","unstructured":"Zambotti F, Carruba MO, Barzaghi F, Vicentini L, Groppetti A, Mantegazza P (1976) Behavioural effects of a new non-phenylethylamine anorexigenic agent: mazindol. Eur J Pharmacol 36: 405?412","journal-title":"Eur J Pharmacol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01294784.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01294784\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01294784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T07:18:45Z","timestamp":1556781525000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01294784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,10]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1994,10]]}},"alternative-id":["BF01294784"],"URL":"https:\/\/doi.org\/10.1007\/bf01294784","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,10]]}}}